IDENTIFICATION OF THE DELETED IN LIVER CANCER 1 GENE, DLC1, AS A CANDIDATE MENINGIOMA TUMOR SUPPRESSOR
- 1 October 2008
- journal article
- Published by Wolters Kluwer Health in Neurosurgery
- Vol. 63 (4) , 771-781
Abstract
OBJECTIVE. Meningiomas are the second most common primary tumors of the central nervous system. Meningiomas at the cranial base pose technical challengeKeywords
This publication has 54 references indexed in Scilit:
- CpG island methylation and expression of tumour-associated genes in lung carcinomaEuropean Journal of Cancer, 2005
- Identification of ATF-3, caveolin-1, DLC-1, and NM23-H2 as putative antitumorigenic, progesterone-regulated genes for ovarian cancer cells by gene profilingOncogene, 2005
- DLC‐1, a Rho GTPase‐activating protein with tumor suppressor function, is essential for embryonic developmentFEBS Letters, 2005
- Analysis of DLC-1 expression in human breast cancerJournal of Cancer Research and Clinical Oncology, 2003
- Promoter hypermethylation of DLC-1, a candidate tumor suppressor gene, in several common human cancersCancer Genetics and Cytogenetics, 2003
- Alterations of the Tumor Suppressor Genes CDKN2A (p16), p14, CDKN2B (p15), and CDKN2C (p18) in Atypical and Anaplastic MeningiomasThe American Journal of Pathology, 2001
- Analysis of human meningiomas for aberrations of theMADH2,MADH4,APM-1 andDCC tumor suppressor genes on the long arm of chromosome 18International Journal of Cancer, 2001
- Gamma knife surgery for skull base meningiomasSurgical Neurology, 1999
- Interaction of the Rho Family Small G Proteins with Kinectin, an Anchoring Protein of Kinesin MotorBiochemical and Biophysical Research Communications, 1996
- The small GTP-binding protein rho regulates the assembly of focal adhesions and actin stress fibers in response to growth factorsCell, 1992